Dolby Laboratories (NYSE:DLB) CMO Sells $647,835.80 in Stock

Key Points

• Dolby Laboratories CMO Todd Pendleton sold 11,876 shares on May 22 at an average price of $54.55, totaling about $647,836. After the sale, he still held 41,480 shares worth roughly $2.26 million.
• The company’s latest earnings topped expectations, with quarterly EPS of $1.37 versus estimates of $1.31 and revenue of $395.63 million versus $385.80 million expected. Revenue rose 7% year over year, and Dolby also issued FY2026 guidance of $4.30 to $4.45 EPS.
• Dolby continues to pay a quarterly dividend, recently distributing $0.36 per share, or $1.44 annualized, for a yield of 2.6%. Analyst sentiment remains constructive overall, with a consensus rating of “Moderate Buy” and a target price of $90.75.

Dolby Laboratories (NYSE:DLB - Get Free Report) CMO Todd Pendleton sold 11,876 shares of the business's stock in a transaction on Friday, May 22nd. The stock was sold at an average price of $54.55, for a total value of $647,835.80. Following the completion of the transaction, the chief marketing officer directly owned 41,480 shares in the company, valued at approximately $2,262,734. This represents a 22.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Dolby Laboratories Stock Performance

Dolby Laboratories stock traded down $0.88 on Wednesday, reaching $55.67. The company's stock had a trading volume of 636,648 shares, compared to its average volume of 769,917. The company has a market cap of $5.27 billion, a price-to-earnings ratio of 22.00 and a beta of 0.86. The business's fifty day moving average price is $59.79 and its 200 day moving average price is $63.20. Dolby Laboratories has a twelve month low of $52.45 and a twelve month high of $77.00.

Dolby Laboratories (NYSE:DLB - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The electronics maker reported $1.37 EPS for the quarter, topping analysts' consensus estimates of $1.31 by $0.06. The company had revenue of $395.63 million for the quarter, compared to analyst estimates of $385.80 million. Dolby Laboratories had a return on equity of 11.47% and a net margin of 17.85%.The business's revenue was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.34 earnings per share. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. As a group, equities analysts forecast that Dolby Laboratories will post 3.22 earnings per share for the current year.

Dolby Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Shareholders of record on Tuesday, May 12th were paid a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $1.44 dividend on an annualized basis and a yield of 2.6%. Dolby Laboratories's payout ratio is currently 56.92%.

Analyst Upgrades and Downgrades

A number of research firms have commented on DLB. Wall Street Zen lowered Dolby Laboratories from a "buy" rating to a "hold" rating in a research note on Saturday, January 31st. Barrington Research reaffirmed an "outperform" rating and set a $90.00 price target on shares of Dolby Laboratories in a research note on Monday, April 27th. Rosenblatt Securities reaffirmed a "buy" rating and set a $85.00 price target on shares of Dolby Laboratories in a research note on Friday, January 30th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Three research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $90.75.

Key Dolby Laboratories News

Here are the key news stories impacting Dolby Laboratories this week:

• Positive Sentiment: Zacks Research raised its FY2026 EPS estimate for Dolby Laboratories to $3.16 from $3.01, signaling better near-term earnings expectations.
• Positive Sentiment: The firm also lifted FY2027 EPS estimates to $3.22 from $3.02 and FY2028 EPS to $3.40 from $3.19, pointing to improving long-term earnings power.
• Positive Sentiment: Several quarterly forecasts were increased as well, including Q4 2026, Q1 2027, Q2 2027, Q4 2027, Q1 2028, and Q2 2028, reinforcing the view that earnings trends are improving.
• Neutral Sentiment: Even after the analyst updates, the broader market consensus for current-year earnings remains at $3.22 per share, so the changes are incremental rather than a major fundamental surprise.
• Negative Sentiment: One offsetting note was a cut to Q3 2026 EPS estimates to $0.39 from $0.65, which suggests some near-term softness before the later-year outlook improves.

Hedge Funds Weigh In On Dolby Laboratories

Several large investors have recently made changes to their positions in the company. Norges Bank bought a new stake in Dolby Laboratories in the fourth quarter valued at about $54,966,000. AQR Capital Management LLC increased its holdings in Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker's stock valued at $128,935,000 after purchasing an additional 592,282 shares during the last quarter. First Trust Advisors LP increased its holdings in Dolby Laboratories by 19.9% in the first quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker's stock valued at $135,431,000 after purchasing an additional 374,405 shares during the last quarter. Alyeska Investment Group L.P. bought a new stake in Dolby Laboratories in the fourth quarter valued at about $23,477,000. Finally, Voloridge Investment Management LLC increased its holdings in Dolby Laboratories by 2,017.9% in the fourth quarter. Voloridge Investment Management LLC now owns 325,499 shares of the electronics maker's stock valued at $20,904,000 after purchasing an additional 310,130 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company's stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company's core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby's licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.